Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 first-in-human study of AB102 in healthy participants
NL-OMON61250Phase 1Recruiting
- Sponsor
- Arcus Biosciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of AB102, sponsored by Arcus Biosciences. Started Jun 2026; status: recruiting.
02
Drugs
AB102
Beyond the preview
Go deeper on NL-OMON61250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61250.